APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 40 filers reported holding APTEVO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $201,000 | +11.7% | 306,449 | +0.1% | 0.00% | – |
| Q3 2019 | $180,000 | -33.6% | 306,191 | +0.3% | 0.00% | – |
| Q2 2019 | $271,000 | -15.0% | 305,365 | -13.7% | 0.00% | – |
| Q1 2019 | $319,000 | -29.4% | 353,948 | -0.7% | 0.00% | – |
| Q4 2018 | $452,000 | -75.0% | 356,420 | +0.1% | 0.00% | – |
| Q3 2018 | $1,810,000 | +3.3% | 356,238 | +1.4% | 0.00% | – |
| Q2 2018 | $1,753,000 | +53.8% | 351,472 | +0.7% | 0.00% | – |
| Q1 2018 | $1,140,000 | -23.4% | 348,858 | -0.6% | 0.00% | – |
| Q4 2017 | $1,488,000 | +24.0% | 350,913 | -33.0% | 0.00% | – |
| Q3 2017 | $1,200,000 | +26.8% | 523,814 | +14.6% | 0.00% | – |
| Q2 2017 | $946,000 | -59.3% | 457,272 | -59.4% | 0.00% | – |
| Q1 2017 | $2,324,000 | +77366.7% | 1,127,451 | +87639.4% | 0.00% | – |
| Q4 2016 | $3,000 | -80.0% | 1,285 | -78.6% | 0.00% | – |
| Q3 2016 | $15,000 | – | 6,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 974,492 | $2,495,000 | 0.55% |
| Perceptive Advisors | 988,133 | $2,530,000 | 0.16% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 38,860 | $99,000 | 0.07% |
| Laurel Wealth Advisors, Inc. | 42,890 | $110,000 | 0.05% |
| CSS LLC/IL | 353,977 | $906,000 | 0.04% |
| GLG Partners LP | 396,486 | $1,015,000 | 0.03% |
| Capital Impact Advisors, LLC | 12,318 | $32,000 | 0.01% |
| Spark Investment Management LLC | 66,000 | $168,000 | 0.01% |
| Peak Asset Management, LLC | 10,000 | $26,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 99,390 | $254,000 | 0.01% |